- Home
- ARQT vs SLG Comparison
ARQT vs SLG Comparison
Compare ARQT & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | SLG |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | 1221 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.1B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ARQT | SLG |
|---|---|---|
| Price | $28.33 | $44.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 17 |
| Target Price | $24.83 | ★ $58.41 |
| AVG Volume (30 Days) | ★ 2.0M | 1.5M |
| Earning Date | 10-28-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 6.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $317,929,000.00 | ★ $661,814,000.00 |
| Revenue This Year | $85.51 | N/A |
| Revenue Next Year | $30.74 | $9.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $40.26 |
| 52 Week High | $31.77 | $70.43 |
Technical Indicators
Market Signals| Indicator | ARQT | SLG |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 42.77 |
| Support Level | $27.55 | $43.68 |
| Resistance Level | $28.90 | $46.51 |
| Average True Range (ATR) | 1.15 | 1.80 |
| MACD | -0.55 | 0.35 |
| Stochastic Oscillator | 18.58 | 56.57 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.